Complexa Names William Leong, Vice President of Chemistry, Manufacturing and Controls Press Release , July 26th, 2018
Cognition Therapeutics Initiates NIA-Funded SPARC Study of Elayta™ to Assess Changes in Synaptic Density and Cognitive Performance in Alzheimer’s Disease Press Release , June 18th, 2018
Medrobotics® Announces $25MM Venture Debt Investment Commitment from Western Technology Investment Press Release , June 14th, 2018
Cognition Therapeutics Initiates NIA-Funded SNAP study of Elayta™ to Measure Toxic Oligomer Displacement and Clearance in Alzheimer’s Disease Press Release , June 5th, 2018
First Patient Dosed in the Complexa Phase 2 Trial of Lead Candidate CXA-10 to Treat a Rare and Severe Form of Kidney Disease, Focal Segmental Glomerulosclerosis Press Release , June 1st, 2018
Medrobotics Receives FDA Clearance for Flexible Transabdominal, Transthoracic Robotic Scope Press Release , February 12th, 2018
Cohera Medical, Inc.® Receives Expedited Access Pathway Designation from FDA for Sylys® Surgical Sealant Press Release, June 9th, 2015
Medrobotics® Corporation Named a Winner at 2015 New England Innovation Awards Press Release, May 11th, 2015
Cohera Medical, Inc.® Receives FDA Approval of First Tissue Adhesive For Internal Use in the U.S. Press Release, February 9th, 2015